Adapalene vs. metronidazole gel for the treatment of rosacea

International Journal of Dermatology

Volumn 44, Issue 3, 2005, Pages 252-255

  Altinyazar, H Cevdet ^a   Koca, Rafet ^a   Tekin, Nilgün Solak ^a   Eştürk, Emel ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPULE; PUSTULE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SCORING SYSTEM; SKIN IRRITATION; SUNLIGHT PROTECTION; TELANGIECTASIA; TREATMENT OUTCOME;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; NAPHTHALENES; ROSACEA; SINGLE-BLIND METHOD;

EID: 15844392406     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02130.x     Document Type: Article

References (19)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584-587.
2. Berg M, Liden S. An epidemiological study of rosacea. Acta Dermatol Venereol 1989; 69: 419-423.
3. Pelwig G, Jansen T. Rosacea. In: Freedberg IM, Eisen A, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine 5th edn, Vol. I. New York: McGraw-Hill, 1999: 785-793.
4. Erdogan FG, Yurtsever P, Aksoy D, et al. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-885.
5. Thiboutot DM. Acne and rosacea. New and emerging therapies. Dermatol Clin 2000; 18: 63-71.
6. McClellan KJ, Noble S. Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 2000; 1: 191-199.
7. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001; 45: 723-730.
8. Gupta AK. Topical metronidazole for rosacea. Skin Ther Lett 2002; 7: 1-6.
9. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994; 130: 319-324.
10. Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994; 130: 359-362.
11. Kligman AM. Topical tretinoin for rosacea: a preliminary report. J Dermatol Treat 1993; 4: 71-73.
12. Galvin SA, Gilbert R, Baker M, et al. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol 1998; 139 (Suppl. 52): 34-40.
13. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998; 134: 679-683.
14. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis 2002; 70: 271-275.
15. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol 1986; 25: 660-663.
16. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol 1998; 139 (Suppl. 52): 3-7.
17. Caron D, Sorba V, Kerrouche N, et al. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997; 36: S110-S112.
18. Brogden RN, Goa KE. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997; 53: 511-519.
19. Millikan LE. Adapalene: an update on newer comparative studies between the various retinoids. Int J Dermatol 2000; 39 784-788.